Jason Plotkin
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 6
- CAR-T cell therapy research 5
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 2
- Co-authors
- Michel Sadelain (5 shared papers)Isabelle Rivière (2 shared papers)Gertrude Gunset (2 shared papers)Maud Condomines (2 shared papers)Maiko Matsushita (1 shared paper)Sjoukje J. C. van der Stegen (1 shared paper)Fabiana Perna (1 shared paper)Zeguo Zhao (1 shared paper)
- Journals
- The Journal of Immunology (2 papers)Science Translational Medicine (1 paper)Molecular Therapy — Oncolytics (1 paper)Cancer Research (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Jason Plotkin
8 papers receiving 2.0k citations
Jason Plotkin's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 1.6k
- Immunology 730
- Genetics 466
- Biomedical Engineering 533
- Molecular Biology 567
Countries citing papers authored by Jason Plotkin
This map shows the geographic impact of Jason Plotkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Plotkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Plotkin more than expected).
Fields of papers citing papers by Jason Plotkin
This network shows the impact of papers produced by Jason Plotkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Plotkin. The network helps show where Jason Plotkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason Plotkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells Hit paper breakdown → | 2015 | 653 |
| 2 | Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity Hit paper breakdown → | 2014 | 444 |
| 3 | 2009 | 443 | |
| 4 | 2003 | 182 | |
| 5 | 2005 | 181 | |
| 6 | 2016 | 71 | |
| 7 | 2015 | 55 | |
| 8 | 2004 | 49 |
About Jason Plotkin
Jason Plotkin is a scholar working on Oncology, Immunology, Molecular Biology, Epidemiology and Genetics, having authored 8 papers that have together received 2.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (2 papers), Genomics and Chromatin Dynamics (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Ubiquitin and proteasome pathways (1 paper), Silicon Carbide Semiconductor Technologies (1 paper) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Oncology (1.6k citations), Immunology (730 citations), Genetics (466 citations), Biomedical Engineering (533 citations) and Molecular Biology (567 citations). Jason Plotkin has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Michel Sadelain, Isabelle Rivière, Gertrude Gunset, Maud Condomines, Maiko Matsushita, Sjoukje J. C. van der Stegen, Fabiana Perna, Zeguo Zhao, Christopher C. Kloss and Leonid Cherkassky. Their work appears in journals such as The Journal of Immunology, Science Translational Medicine, Molecular Therapy — Oncolytics, Cancer Research and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.